Lauren Santye, Assistant Editor & Laurie Toich, Assistant Editor

home / authors / lauren-santye-assistant-editor-and-laurie-toich-assistant-editor

Articles

What are the Implications of Transparency Legislation on Specialty Pharmacy?

What are the Implications of Transparency Legislation on Specialty Pharmacy?

Lauren Santye, Assistant Editor & Laurie Toich, Assistant Editor
July 13th 2017

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how recently proposed transparency legislation may affect specialty pharmacies.

Read More

What is the Most Important Strategy for Selecting a Specialty Pharmacy Partner?

What is the Most Important Strategy for Selecting a Specialty Pharmacy Partner?

Lauren Santye, Assistant Editor & Laurie Toich, Assistant Editor
June 23rd 2017

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses optimal strategies when choosing a specialty pharmacy to partner with.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD